/
SILO
$5.83-$1.90 (-24.58%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$8.7M
1M shares
52-week range
$3.32 – $15.15
21% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
80.88%
Hard to borrow
Change$-101.05
Silo Pharma, Inc. Common Stock
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
www.silopharma.com- Employees
- 3
- IPO / List date
- Jan 5, 2012
- HQ
- SARASOTA, FL
Held by traders on TradeandTell
No one on the platform currently holds SILO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SILO as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-06-03 | 1-for-15reverse |
| 2022-09-15 | 1-for-50reverse |
Recent trades on TradeandTell
No one on the platform has traded SILO yet.
